Short description
QurCan Therapeutics (formerly known as Nanology Labs) is a biotech company developing next-generation nanoparticles for gene/chemotherapy.
Description
Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents (GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Toronto, Ontario, Canada, North America
Founded on
April 1, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Absolutely Noaccess, Blurry Noaccess, Noaccessforu, Blurry Noaccess, Noaccess, Uh Ohhhh, Noway Youcantaccess
Sign in for full access
Founders
Mohammad Ali Amini, Shirley Wu